Dopo l'orario di chiusura: 29.23

Immunovant Inc (IMVT)

Immunovant Inc Borsa (IMVT) Ultime notizie

Immunovant Inc (IMVT)

Immunovant Inc Borsa (IMVT) Ultime notizie

Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by E Fund Management Co. Ltd. - Defense World

Trading (IMVT) With Integrated Risk Controls - Stock Traders Daily

Immunovant Inc (IMVT) did well last session? - US Post News

ImmunityBio, Inc. (NASDAQ:IBRX) Shares Purchased by Private Advisor Group LLC - Defense World

Roivant Deals Again, Sending Dermavant to Organon in Sale Worth Up to $1.2B - BioSpace

Quest Partners LLC Grows Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Recent Insider Activity Could Benefit Immunovant Inc (IMVT) - Knox Daily

IBRX Stock on the Rise: A Promising Investment - The InvestChronicle

WINTON GROUP Ltd Buys Shares of 20,675 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

IVV And The S&P 500: How Bad Could It Get? (NYSEARCA:IVV) - Seeking Alpha

Headlands Technologies LLC Buys New Stake in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Immunic (NASDAQ:IMUX) Raised to Strong-Buy at EF Hutton Acquisition Co. I - MarketBeat

A new trading data show Immunovant Inc (IMVT) is showing positive returns. - SETE News

Balance Sheet Dive: Immunovant Inc (IMVT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Immunovant, Inc. (NASDAQ:IMVT) Stake Lessened by Los Angeles Capital Management LLC - Defense World

Victory Capital Management Inc. Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Victory Capital Management Inc. Cuts Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

TD Asset Management Inc Sells 32,242 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by TD Asset Management Inc - Defense World

First Turn Management LLC Buys 182,535 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

FY2026 EPS Estimates for Immunovant, Inc. (NASDAQ:IMVT) Decreased by Analyst - Defense World

Immunovant, Inc. to Post FY2026 Earnings of ($2.82) Per Share, Leerink Partnrs Forecasts (NASDAQ:IMVT) - MarketBeat

Bank of New York Mellon Corp Has $6.61 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Bank of New York Mellon Corp - Defense World

What the Options Market Tells Us About Immunovant - Benzinga

A stock that deserves closer examination: Immunovant Inc (IMVT) - US Post News

Financial Metrics Exploration: Understanding Immunovant Inc (IMVT) Through Ratios - The Dwinnex

Immunovant’s (IMVT) Buy Rating Reaffirmed at HC Wainwright - Defense World

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - MSN

Roivant reveals Phase 1b results for new pulmonary treatment - Investing.com

Immunovant (NASDAQ:IMVT) Given Buy Rating at HC Wainwright - MarketBeat

Immunovant Inc (IMVT) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Immunovant (NASDAQ:IMVT) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

Immunovant (NASDAQ:IMVT) Shares Down 3.6% - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Immunovant Sees Unusually High Options Volume (NASDAQ:IMVT) - Defense World

Immunovant stock falls 8% amid Graves' disease program update (NASDAQ:IMVT) - Seeking Alpha

Immunovant’s Confidence In Graves’ Disease Builds - Scrip

Immunovant (NASDAQ:IMVT) Earns "Overweight" Rating from Cantor Fitzgerald - MarketBeat

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - Benzinga

Immunovant reports promising batoclimab trial results for Graves' Disease - Investing.com

What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday? - Benzinga

Immunovant Sees Unusually High Options Volume (NASDAQ:IMVT) - MarketBeat

This trade activity should not be overlooked: Immunovant Inc (IMVT) - SETE News

Top 2 Health Care Stocks That May Collapse This Quarter - Benzinga

Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses - Pharmaceutical Technology

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - Yahoo Finance

Immunovant Advances Groundbreaking Therapy in Graves’ Disease Trials - TipRanks

Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses - Yahoo Finance

Roivant Provides Update on Graves’ Disease Development Program - ForexTV.com

Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses - Clinical Trials Arena

Roivant Sciences (ROIV) Provides Update on Graves’ Disease Development Program - StreetInsider.com

Roivant Provides Update on Graves’ Disease Development Program - Yahoo Finance

Immunovant Provides Update on Graves’ Disease Development Program - ForexTV.com

Immunovant Provides Update on Graves’ Disease Development Program - StockTitan

Principal Financial Group Inc. Sells 23,033 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Principal Financial Group Inc. Has $14.78 Million Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Principal Financial Group Inc. Sells 38,239 Shares of Blackstone Mortgage Trust, Inc. (NYSE:BXMT) - Defense World

Immunovant (NASDAQ:IMVT) Trading Up 4.9% - MarketBeat

Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report? - Yahoo Finance

Insider Buying: Mack Richard, Claros Mortgage Trust Inc [CMTG] CEO & CHAIRMAN invested 40,000 shares - Knox Daily

Immunovant to Host Graves’ Disease Program Update on September 9, 2024 - StockTitan

The Attractiveness of Investing In Griffon Corp. (GFF) is Growing - Knox Daily

(IMVT) Trading Signals - Stock Traders Daily

Allspring Global Investments Holdings LLC Sells 4,144 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

A look into Immunovant Inc (IMVT)’s deeper side - SETE News

Are Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%? - Yahoo Finance

Short Interest in Immunovant, Inc. (NASDAQ:IMVT) Grows By 9.1% - MarketBeat

Q2 2025 EPS Estimates for Immunovant, Inc. (NASDAQ:IMVT) Cut by Analyst - Defense World

Research Analysts Offer Predictions for Immunovant, Inc.'s Q2 2025 Earnings (NASDAQ:IMVT) - MarketBeat

Can you now get a good deal on Immunovant Inc’s shares? - US Post News

Simile a IMVT